Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

178.34 +0.02 (+0.01%)

Streaming Delayed Price Updated: 2:38 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Shockwave Medical Stock With Rising Relative Strength ↗

April 11, 2023

On Tuesday, Shockwave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 67 to 75.

Via Investor's Business Daily

Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System

April 03, 2023

From Masimo

Via Business Wire

Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom™ Smartwatch

March 28, 2023

From Masimo

Via Business Wire

Expert Ratings for Masimo ↗

February 22, 2023

Via Benzinga

The Latest Analyst Ratings for Masimo ↗

January 11, 2023

Via Benzinga

Masimo Announces Changes to Governance Structure and Practices

March 23, 2023

From Masimo Corporation

Via Business Wire

European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring

March 15, 2023

From Masimo

Via Business Wire

New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery

March 09, 2023

From Masimo

Via Business Wire

Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

March 07, 2023

From Masimo

Via Business Wire

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

March 06, 2023

From Masimo

Via Business Wire

$300B California Teachers Pension Fund Joins Politan Capital In Legal Action Against Masimo CEO's Employment Agreement ↗

March 03, 2023

Via Benzinga

CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO’s Employment Agreement

March 03, 2023

From Politan Capital Management

Via Business Wire

Masimo to Present in 44th Annual Raymond James Institutional Investors Conference

March 02, 2023

From Masimo

Via Business Wire

Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results

February 28, 2023

From Masimo

Via Business Wire

Analyst Says This MedTech Giant Stock Offers 'Too Much Optionality,' Upgrades Rating ↗

February 22, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 ↗

February 22, 2023

Via Benzinga

New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy

February 21, 2023

From Masimo

Via Business Wire

Masimo Centroid® Receives Innovative Technology Designation from Vizient

February 15, 2023

From Masimo

Via Business Wire

Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28

February 14, 2023

From Masimo

Via Business Wire

Thoughts For Thursday: Risk-off, Risk-on ↗

February 09, 2023

The one foot forward, one foot backward action continues on Wall Street, though yesterday it was more like three or four steps backward. It seems Q1 earnings jitters are responsible.

Via Talk Markets

NeurAxis: Should You Buy This IPO? ↗

February 08, 2023

As NeurAxis is ready to launch its IPO, we take a closer look to see if investors should be buying into the hype.

Via Talk Markets

Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)

January 30, 2023

From Masimo

Via Business Wire

Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

January 23, 2023

On Monday, Intuitive Surgical stock had its Relative Strength (RS) Rating upgraded to 81, up from 73 a day earlier.

Via Investor's Business Daily

InMode Stock Glowing Again As Cosmetic Surgery Market Recovers ↗

January 23, 2023

The upwardly revised 75 RS Rating shows InMode stock outperformed 75% of all stocks over the past year. Its other ratings are even better.

Via Investor's Business Daily

Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery

January 23, 2023

From Masimo

Via Business Wire

Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1™ Watch

January 18, 2023

From Masimo

Via Business Wire

How Masimo Is Taking On Electronics Giant Apple — And Winning ↗

January 11, 2023

Apple could be on the hook for a royalty tied to its Apple Watch.

Via Investor's Business Daily

Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case ↗

January 10, 2023

Via Benzinga

ITC Judge Rules Apple Violated U.S. Trade Laws by Infringing Masimo Pulse Oximeter Patent

January 10, 2023

From Masimo

Via Business Wire

New Study Evaluates the Performance of Masimo SpHb® Noninvasive Spot-Check Hemoglobin in the Emergency Department

January 09, 2023

From Masimo

Via Business Wire

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.